Pivotal Study of the Treatment of Chronic Subdural Hematoma via Middle Meningeal Artery Embolization with the NeoCastTM Embolic System (RADIANT)

Submitted by lachlan.carlsen on Mon, 02/02/2026 - 10:42

The primary objective of this pivotal study is the evaluation of the safety and effectiveness of MMA embolization with the Arsenal Medical NeoCast Embolic System for the treatment of cSDH in surgical patients. This study will be conducted under U.S. Investigational Device Exemption (IDE).

Principal Investigator(s)
Michael Levitt, MD
Award Info

Arsenal Medical Inc.